More importantly, it was found that LincRNA-p21 silencing alleviated pathological changes in diabetic kidney, and reduced ECM in mouse mesangial cells stimulated by high glucose,10 indicating the involvement of LincRNA-p21 in kidney disease. This evidence concerns the gene CDKN1A and kidney disorder.